Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • US Food and Drug...

    Tag: u.s. food and drug administration

    You Searched For "US Food and Drug Administration"
    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Medical Dialogues Bureau11 Oct 2019 10:00 AM IST
    "The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
    Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore

    Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore

    Farhat Nasim1 Oct 2019 2:13 PM IST
    The company has entered into an asset purchase agreement to sell its right, title and interest in Zypitamag, along with applicable registrations and...
    Roche gets USFDA clearance for cobas pro solutions for diagnostics labs

    Roche gets USFDA clearance for cobas pro solutions for diagnostics labs

    Medical Dialogues Bureau17 Sept 2019 9:15 AM IST
    With the cobas pro integrated solutions, laboratories are now able to run tests faster on less equipment, automate manual tasks and deliver results...
    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units

    Medical Dialogues Bureau6 Sept 2019 1:03 PM IST
    The establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore

    Farhat Nasim27 Aug 2019 2:30 PM IST
    "Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD...
    Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

    Emcure Pharma gets USFDA Warning Letter for Manufacturing Violations at Pune plant

    Medical Dialogues Bureau16 Aug 2019 9:45 AM IST
    In the letter, the USFDA said inspectors during February 11-20 this year found significant deviations from standard manufacturing practices at Emcure...
    Radiation Protection absolute necessity for Medical Professionals- Mr Satyaki Banerjee, CEO, Kiran Medical Systems, Trivitron Healthcare

    Radiation Protection absolute necessity for Medical Professionals- Mr Satyaki Banerjee, CEO, Kiran Medical Systems, Trivitron Healthcare

    Deepanjana Sarkar Sarkar9 Aug 2019 3:39 PM IST
    New Delhi: In hospitals and diagnostic centers, healthcare providers need to work with various ionizing radiation emitting medical equipment to...
    Dr Reddys gets two USFDA observations for Vizag plants

    Dr Reddys gets two USFDA observations for Vizag plants

    Farhat Nasim24 Jun 2019 11:09 AM IST
    Hyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
    Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan

    Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan

    Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
    Online pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan,...
    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules

    Farhat Nasim28 May 2019 10:00 AM IST
    The approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
    Pfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patients

    Pfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patients

    Farhat Nasim19 May 2019 9:45 AM IST
    The efficacy of Fragmin in children was based on a single trial with 38 pediatric patients with symptomatic deep vein thrombosis and/or pulmonary...
    Cipla gets no USFDA observations for Indore facility

    Cipla gets no USFDA observations for Indore facility

    Farhat Nasim18 May 2019 9:45 AM IST
    The US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok